Transforming the Perjeta (Pertuzumab) Market in 2025: Rising Breast Cancer Incidence Driving Growth Of The Herceptin Biosimilars Market

What Is the Expected Size and Growth Rate of the Perjeta (Pertuzumab) Market?_x000D_
The market value of perjeta (pertuzumab) has seen quick expansion in the past few years. From $935.92 million in 2024, it's expected to increase to $1,084.80 million in 2025, with a compound annual growth rate (CAGR) of 15.9%. The rise in the historic phase can be tied down to an upsurge in its application within oncology, the growing demand for ADCs, request for targeted and less harmful treatments, a boost from inorganic growth, and the need for more personalized medicine._x000D_
_x000D_
In the coming years, the perjeta (pertuzumab) market is anticipated to experience swift expansion, with its value predicted to reach $1,932.66 million in 2029, growing at a compound annual growth rate (CAGR) of 15.5%. This predicted growth during the forecast duration can be linked to factors such as the increasing cases of breast cancer, enhanced interest in ADCs for hematologic malignancies, the rising prevalence of cancer, unfulfilled medical requirements, and an uptick in pharmaceutical research & development for cancer immunotherapy. Other notable trends influencing the market in the forecast span include the introduction of biosimilars in oncology, the creation of biosimilars and generics, breakthroughs in drug formulations, further advancements in cancer immunotherapy studies, and the increased prominence of combination therapies._x000D_
_x000D_
What Factors Are Fueling Growth in the Perjeta (Pertuzumab) Market?_x000D_
The upsurge in the occurrence of breast cancer is anticipated to fuel the advancement of the Perjeta (pertuzumab) market. Breast cancer is a disease characterized by the growth of malevolent cells in the breast tissue, usually stemming from the ducts or lobules. This growing prevalence is linked to shifts in lifestyle, such as an increase in obesity and sedentary habits, along with better early detection methods through comprehensive screening programs. Perjeta (pertuzumab) is employed to manage HER2-positive breast cancer by focusing on the HER2 receptor and is typically mixed with trastuzumab and chemotherapy to enhance treatment results. For example, Ray of Light Wales, a not-for-profit charity in the UK, stated in October 2023 that about 600,000 individuals in the UK are living post breast cancer diagnosis, and this figure is forecasted to soar to 1.2 million by 2030. Therefore, the escalating incidence of breast cancer is catalyzing the growth of the herceptin biosimilars market._x000D_
_x000D_
Get Your Free Sample Now - Explore Exclusive Market Insights:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=19917&type=smp_x000D_
_x000D_
Which Leading Companies Are Shaping the Growth of the Perjeta (Pertuzumab) Market?_x000D_
Major companies operating in the perjeta (pertuzumab) market include Roche Holding AG _x000D_
_x000D_
What Are the Major Trends Shaping the Perjeta (Pertuzumab) Market?_x000D_
The Perjeta (pertuzumab) market is largely centered on the creation of technologically superior solutions like subcutaneous combination therapies, with a particular emphasis on enhancing patient results and ease of treatment. Such therapies combine two or more drugs in a single injection, delivered under the skin, to manage a specific health issue. For example, in November 2023, Chugai Pharmaceutical Co., Ltd., a Japanese pharmaceutical firm, introduced Phesgo, designed for the subcutaneous treatment of HER2-positive breast cancer and advanced or recurring HER2-positive colorectal cancer. This groundbreaking subcutaneous method merges the monoclonal antibodies pertuzumab and trastuzumab with vorhyaluronidase alfa. It can be administered in a mere 5 to 8 minutes, a notable reduction in time compared to traditional intravenous injections. Specifically aimed at patients suffering from advanced or recurrent HER2-positive colorectal cancer, Phesgo represents the first solution of its kind available for this affliction._x000D_
_x000D_
What Are the Key Segments of the Perjeta (Pertuzumab) Market?_x000D_
The perjeta (pertuzumab)market covered in this report is segmented - _x000D_
_x000D_
1) By Type: Human source; Animal source_x000D_
2) By Product: Monoclonal Antibody; Biologic Drug_x000D_
3) By Indication: Early Breast Cancer; Metastatic Breast Cancer_x000D_
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies_x000D_
_x000D_
Pre-Book Your Report Now For A Swift Delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/perjeta-pertuzumab-global-market-report_x000D_
_x000D_
Which Region Dominates the Perjeta (Pertuzumab) Market?_x000D_
North America was the largest region in the perjeta (pertuzumab) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the perjeta (pertuzumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
What Is Covered In The Perjeta (Pertuzumab) Global Market Report?_x000D_
_x000D_
- Market Size Analysis: Analyze the perjeta (pertuzumab) Market Size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the perjeta (pertuzumab) market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall perjeta (pertuzumab) market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the perjeta (pertuzumab) market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Unlock Exclusive Market Insights - Purchase Your Research Report Now!_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19917_x000D_
_x000D_

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.